Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.
Glioblastoma multiforme (GBM) is the most common and aggressive primary intracranial brain tumor in adults with a mean survival of 14 to 15 months. Aberrant activation of the epidermal growth factor receptor (EGFR) plays a significant role in GBM progression, with amplification or overexpression of...
Main Authors: | Martin J Hicks, Maria J Chiuchiolo, Douglas Ballon, Jonathan P Dyke, Eric Aronowitz, Kosuke Funato, Viviane Tabar, David Havlicek, Fan Fan, Dolan Sondhi, Stephen M Kaminsky, Ronald G Crystal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5053413?pdf=render |
Similar Items
-
Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
by: David F Havlicek, et al.
Published: (2020-01-01) -
Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma
by: Marc-Eric Halatsch, et al.
Published: (2012-05-01) -
Adult Human Glioblastomas Harbor Radial Glia-like Cells
by: Rong Wang, et al.
Published: (2020-02-01) -
Assessment of epidermal growth factor receptor status in glioblastomas
by: Hui-Jun Zhu, et al.
Published: (2013-10-01) -
Assessment of epidermal growth factor receptor status in glioblastomas
by: Hui-Jun Zhu, et al.
Published: (2013-10-01)